KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response R…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...

Denison Announces Closing of Transaction with Skyharbour and Formation of Four Prospective Exploration Joint Ventures Proximal to Wheeler River

Denison Mines Corp. ("Denison" or the "Company") (TSX: DML; NYSE American: DNN) is pleased to announce that it has closed the previously announced transaction (the "Transaction") with Skyharbour ...